VTAK RA MEDICAL SYSTEMS INC.

Catheter Precision Makes NYSE American Section 610(b) Public Announcement

Catheter Precision Makes NYSE American Section 610(b) Public Announcement

Fort Mill, S.C., April 17, 2025 (GLOBE NEWSWIRE) -- -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2024, filed March 31, 2025, with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included a Substantial Doubt Regarding Going Concern paragraph. See further discussion in footnote 1 to the Company's consolidated financial statements included in the Company's Annual Report on Form 10-K.

This announcement is made pursuant to NYSE American Company Guide Section 610(b), which requires separate public announcement of the receipt of an audit opinion containing a going concern paragraph. This announcement does not represent any change or amendment to the Company's consolidated financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2024.

CONTACTS:

At the Company

David Jenkins

973-691-2000





EN
17/04/2025

Underlying

VTAKRA MEDICAL SYSTEMS INC.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RA MEDICAL SYSTEMS INC.

 PRESS RELEASE
Free
VTAK RA MEDICAL SYST...

Catheter Precision’s LockeT Suture Retention Device to be Featured in ...

Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 FORT MILL, S.C., March 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the . The event, co-hosted by the Academy for Continued Healthcare Learning (ACHL) and ISLAA Foundation, will take place from March 5-6, 2026, at the Biltmore Hotel in Los Angeles, California. The ISLAA meeting is a ...

March 6, 2026 1 EN
 PRESS RELEASE
Free
VTAK RA MEDICAL SYST...

Catheter Precision Announces Strategic Sale of Non-Core Assets to Stre...

Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue Upside FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) --  Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive agreement to divest its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer. Following a comprehensive portf...

February 19, 2026 1 EN
 PRESS RELEASE
Free
VTAK RA MEDICAL SYST...

VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fl...

VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital Allocation into High-Growth Infrastructure with Scalable Fleet Expansion and Long-Term Equity Upside Fort Mill, S.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced a strategic minority investment in Fly Flyte, Inc. (“Flyte”), an FAA-certified regional aviat...

February 17, 2026 1 EN
 PRESS RELEASE
Free
VTAK RA MEDICAL SYST...

Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Inst...

Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth VTAK has Agreed to Terminate its At-The-Market (“ATM”) Equity Offering Program Company Strengthens Balance Sheet and Aligns Institutional Capital for Long-Term Value Creation FORT MILL, S.C., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a leader in advanced electrophysiology solutions, today announced that it has agreed to the termination of its at-the-market (“ATM”) equity offering program and has com...

February 12, 2026 1 EN
 PRESS RELEASE
Free
VTAK RA MEDICAL SYST...

Catheter Precision’s LockeT Suture Retention Device to be Featured in ...

Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference FORT MILL, S.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a pioneer in medical technology for the cardiac electrophysiology market, today announced that its LockeT suture retention device will be highlighted during live procedural cases at the  conference. The event, hosted by Scripps Health, will take place from February 11–13, 2026, at the Hyatt Regency La Jolla at Aventine in San Diego. The Scri...

February 5, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch